M. Ancelin, J. Scali, and K. Ritchie, Hormonal therapy and depression: Are we overlooking an important therapeutic alternative?, Journal of Psychosomatic Research, vol.62, issue.4, pp.473-485, 2007.
DOI : 10.1016/j.jpsychores.2006.12.019

URL : https://hal.archives-ouvertes.fr/inserm-00138466

P. Schmidt, L. Nieman, and M. Danaceau, Estrogen replacement in perimenopause-related depression: A preliminary report, American Journal of Obstetrics and Gynecology, vol.183, issue.2, pp.414-420, 2000.
DOI : 10.1067/mob.2000.106004

C. Soares, O. Almeida, H. Joffe, and L. Cohen, Efficacy of Estradiol for the Treatment of Depressive Disorders in Perimenopausal Women, Archives of General Psychiatry, vol.58, issue.6, pp.529-534, 2001.
DOI : 10.1001/archpsyc.58.6.529

L. Cohen, C. Soares, J. Poitras, J. Prouty, A. Alexander et al., Short-Term Use of Estradiol for Depression in Perimenopausal and Postmenopausal Women: A Preliminary Report, American Journal of Psychiatry, vol.160, issue.8
DOI : 10.1176/appi.ajp.160.8.1519

M. Morrison, M. Kallan, T. Have, T. Katz, I. Tweedy et al., Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial, Biological Psychiatry, vol.55, issue.4, pp.406-412, 2004.
DOI : 10.1016/j.biopsych.2003.08.011

J. Zweifel, O. Brien, and W. , A meta-analysis of the effect of hormone replacement therapy upon depressed mood, Psychoneuroendocrinology, vol.22, issue.3, pp.189-212, 1997.
DOI : 10.1016/S0306-4530(96)00034-0

J. Rymer and E. Morris, Extracts from "Clinical Evidence": Menopausal symptoms, BMJ, vol.321, issue.7275, pp.1516-1519, 2000.
DOI : 10.1136/bmj.321.7275.1516

C. Soares, H. Arsenio, and H. Joffe, Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women, Menopause, vol.13, issue.5, pp.780-786, 2006.
DOI : 10.1097/01.gme.0000240633.46300.fa

3. The and . Group, Vascular factors and risk of dementia: Design of the three city study and baseline characteristics of the study population, Neuroepidemiology, vol.22, issue.6, pp.316-325, 2003.

L. Berkman, C. Berkman, and S. Kasl, DEPRESSIVE SYMPTOMS IN RELATION TO PHYSICAL HEALTH AND FUNCTIONING IN THE ELDERLY, American Journal of Epidemiology, vol.124, issue.3, pp.372-388, 1986.
DOI : 10.1093/oxfordjournals.aje.a114408

L. Radloff and B. Locke, The community mental health assessment survey and CES-D scale, 1986.

D. Sheehan, Y. Lecrubier, and K. Sheehan, The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10, J Clin Psychiatry, vol.59, pp.22-33, 1998.

K. Ritchie, S. Artero, and I. Beluche, Prevalence of DSM--IV psychiatric disorder in the French elderly population, The British Journal of Psychiatry, vol.184, issue.2, pp.147-152, 2004.
DOI : 10.1192/bjp.184.2.147

M. Lawton, Scales to measure competence in everyday activities, Psychopharmacol Bull, vol.24, issue.4, pp.609-614, 1988.

S. Katz, A. Ford, R. Moskowitz, and M. Jaffee, Studies of Illness in the Aged, JAMA, vol.185, issue.12, pp.914-919, 1963.
DOI : 10.1001/jama.1963.03060120024016

M. Folstein, S. Folstein, and P. Mchugh, ???Mini-mental state???, Journal of Psychiatric Research, vol.12, issue.3, pp.189-198, 1975.
DOI : 10.1016/0022-3956(75)90026-6

C. Ribet and F. Derriennic, Age, working conditions, and sleep disorders: a longitudinal analysis in the French cohort, Sleep, vol.22, issue.4, pp.491-504, 1999.

. American-psychiatric-association, Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) American Psychiatric Association, 1994.

S. Resnick and V. Henderson, Hormone Therapy and Risk of Alzheimer Disease, JAMA, vol.288, issue.17, pp.2170-2172, 2002.
DOI : 10.1001/jama.288.17.2170

P. Zandi, M. Carlson, and B. Plassman, Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women: The Cache County Study, Obstetrical & Gynecological Survey, vol.58, issue.3, pp.2123-2129, 2002.
DOI : 10.1097/01.OGX.0000055761.75837.23

M. Whooley, D. Grady, and J. Cauley, Postmenopausal estrogen therapy and depressive symptoms in older women, Journal of General Internal Medicine, vol.48, issue.8, pp.535-541, 2000.
DOI : 10.1046/j.1525-1497.2000.04029.x

L. Radloff, The CES-D Scale: A Self-Report Depression Scale for Research in the General Population, Applied Psychological Measurement, vol.1, issue.3, pp.385-401, 1977.
DOI : 10.1177/014662167700100306

M. Ancelin and K. Ritchie, Lifelong Endocrine Fluctuations and Related Cognitive Disorders, Current Pharmaceutical Design, vol.11, issue.32, pp.4229-4252, 2005.
DOI : 10.2174/138161205774913228

URL : https://hal.archives-ouvertes.fr/inserm-00243083

L. Fitzpatrick, C. Pace, and B. Wiita, Comparison of Regimens Containing Oral Micronized Progesterone or Medroxyprogesterone Acetate on Quality of Life in Postmenopausal Women: A Cross-Sectional Survey, Journal of Women's Health & Gender-Based Medicine, vol.9, issue.4, pp.381-387, 2000.
DOI : 10.1089/15246090050020691

B. Sherwin, The Impact of Different Doses of Estrogen and Progestin on Mood and Sexual Behavior in Postmenopausal Women*, The Journal of Clinical Endocrinology & Metabolism, vol.72, issue.2, pp.336-343, 1991.
DOI : 10.1210/jcem-72-2-336

I. Bjorn, M. Bixo, K. Nojd, S. Nyberg, and T. Backstrom, Negative mood changes during hormone replacement therapy: A comparison between two progestogens, American Journal of Obstetrics and Gynecology, vol.183, issue.6, pp.1419-1426, 2000.
DOI : 10.1067/mob.2000.107781

L. Andreen, M. Bixo, S. Nyberg, I. Sundstrom-poromaa, and T. Backstrom, Progesterone effects during sequential hormone replacement therapy, European Journal of Endocrinology, vol.148, issue.5, pp.571-577, 2003.
DOI : 10.1530/eje.0.1480571

I. Odmark, T. Backstrom, B. Jonsson, and M. Bixo, Well-being at onset of hormone replacement therapy: comparison between two continuous combined regimens, Climacteric, vol.305, issue.1, pp.92-102, 2004.
DOI : 10.1056/NEJM199801223380401

J. Cummings and L. Brizendine, Comparison of physical and emotional side effects of progesterone or medroxyprogesterone in early postmenopausal women, Menopause, vol.9, issue.4, pp.253-263, 2002.
DOI : 10.1097/00042192-200207000-00006

A. Cagnacci, S. Arangino, F. Baldassari, C. Alessandrini, S. Landi et al., A comparison of the central effects of different progestins used in hormone replacement therapy, Maturitas, vol.48, issue.4, pp.456-462, 2004.
DOI : 10.1016/j.maturitas.2003.10.003

L. Cohen, C. Soares, A. Vitonis, M. Otto, and B. Harlow, Risk for New Onset of Depression During the Menopausal Transition, Archives of General Psychiatry, vol.63, issue.4, pp.385-390, 2006.
DOI : 10.1001/archpsyc.63.4.385

N. Col, J. Guthrie, M. Politi, and L. Dennerstein, Duration of vasomotor symptoms in middle-aged women, Menopause, vol.16, issue.3, pp.453-457, 2009.
DOI : 10.1097/gme.0b013e31818d414e

N. Woods, K. Smith-dijulio, D. Percival, E. Tao, M. A. Mitchell et al., Depressed mood during the menopausal transition and early postmenopause, Menopause, vol.15, issue.2, pp.223-232, 2008.
DOI : 10.1097/gme.0b013e3181450fc2

C. Soares, Depression during the menopausal transition, Menopause, vol.15, issue.2, pp.207-209, 2008.
DOI : 10.1097/gme.0b013e31816381e9

R. Mcintyre, J. Konarski, and S. Grigoriadis, Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship, Canadian Medical Association Journal, vol.172, issue.1, pp.57-59, 2005.
DOI : 10.1503/cmaj.1040517

L. Cohen, C. Soares, and H. Joffe, Diagnosis and management of mood disorders during the menopausal transition, The American Journal of Medicine, vol.118, issue.12, pp.93-97, 2005.
DOI : 10.1016/j.amjmed.2005.09.042

C. Soares, H. Joffe, and A. Viguera, Paroxetine Versus Placebo for Women in Midlife After Hormone Therapy Discontinuation, The American Journal of Medicine, vol.121, issue.2, pp.159-162, 2008.
DOI : 10.1016/j.amjmed.2007.10.007

L. Altshuler, L. Cohen, M. Moline, D. Kahn, D. Carpenter et al., The Expert Consensus Guideline Series. Treatment of depression in women, Postgrad Med, pp.1-107, 2001.

S. Skouby, F. Azzawi, and D. Barlow, Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy, Maturitas, vol.51, issue.1, pp.8-14, 2005.
DOI : 10.1016/j.maturitas.2005.02.019

D. Grady and G. Sawaya, Discontinuation of postmenopausal hormone therapy, The American Journal of Medicine, vol.118, issue.12, pp.163-165, 2005.
DOI : 10.1016/j.amjmed.2005.09.051